Acetylcholinesterase, Butyrylcholinesterase, Internal medicine, Endocrinology and Biochemistry are his primary areas of study. His Acetylcholinesterase research is classified as research in Enzyme. He interconnects In vitro, Cocaine Esterase, Mutant and Ghrelin in the investigation of issues within Butyrylcholinesterase.
In the field of Internal medicine, his study on Sciatic nerve overlaps with subjects such as Chlorpyrifos. His Sciatic nerve research focuses on Guinea pig and how it connects with Anatomy. His Biochemistry research is multidisciplinary, incorporating perspectives in Molecular biology and Ligand.
The scientist’s investigation covers issues in Acetylcholinesterase, Internal medicine, Endocrinology, Butyrylcholinesterase and Biochemistry. His work carried out in the field of Acetylcholinesterase brings together such families of science as Enzyme assay, Molecular biology and Cholinesterase. His Internal medicine research integrates issues from Axoplasmic transport and Anatomy.
The various areas that Stephen Brimijoin examines in his Axoplasmic transport study include Ligature, Biophysics, Dopamine β hydroxylase, Organelle and Methionine. His biological study deals with issues like Neuroscience, which deal with fields such as Neurite. His Butyrylcholinesterase research includes elements of Ghrelin, Hydrolase, Cocaine Esterase, Antibody and Pharmacology.
His primary scientific interests are in Butyrylcholinesterase, Pharmacology, Hydrolase, Biochemistry and Cholinesterase. His Butyrylcholinesterase research is within the category of Enzyme. Stephen Brimijoin has researched Pharmacology in several fields, including Viral vector, Addiction, Hydrolase Gene and Genetic enhancement.
In his work, Binding site and Ligand is strongly intertwined with Allosteric regulation, which is a subfield of Cholinesterase. Stephen Brimijoin is interested in Aché, which is a field of Acetylcholinesterase. His Ghrelin study is focused on Endocrinology and Internal medicine.
Stephen Brimijoin mostly deals with Butyrylcholinesterase, Pharmacology, Hydrolase, Internal medicine and Endocrinology. His Butyrylcholinesterase study integrates concerns from other disciplines, such as Cholinesterase, Ventral striatum, Cocaine Esterase, Viral vector and Toxicity. His Toxicity study combines topics in areas such as Molecular biology, Gene expression and Immunogenicity.
His studies in Pharmacology integrate themes in fields like Antibody, Saline, Hydrolase Gene and Clinical trial. His Hydrolase study combines topics from a wide range of disciplines, such as Self-administration, Progressive ratio, Drug seeking and Pharmacology toxicology. His Toxic potential research incorporates elements of Acetylcholinesterase, Aché and Enzyme.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase STEPS TOWARD NOVEL DRUGS FOR TREATING ALZHEIMER'S DISEASE
Yuan Ping Pang;Polly Quiram;Tanya Jelacic;Feng Hong.
Journal of Biological Chemistry (1996)
Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.
Bin Li;Judith A. Stribley;Judith A. Stribley;Andreea Ticu;Weihua Xie.
Journal of Neurochemistry (2002)
Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig
Stephen Brimijoin;Stephen Brimijoin;Jan M. Lundberg;Jan M. Lundberg;Ernst Brodin;Ernst Brodin;Tomas Ho¨kfelt;Tomas Ho¨kfelt.
Brain Research (1980)
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.
T Rees;P.I Hammond;H Soreq;S Younkin.
Neurobiology of Aging (2003)
Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics
S. Brimijoin.
Progress in Neurobiology (1983)
Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats.
Johannes Jakobsen;Stephen Brimijoin;Kenneth Skau;Per Sidenius.
Diabetes (1981)
1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo
Timothy D Veenstra;Kirsten Prüfer;Carol Koenigsberger;Stephen W Brimijoin.
Brain Research (1998)
Antipeptide antibodies confirm the topology of the human norepinephrine transporter
Michael Brüss;Rainer Hammermann;Stephen Brimijoin;Heinz Bönisch.
Journal of Biological Chemistry (1995)
Re-engineering butyrylcholinesterase as a cocaine hydrolase
Hong Sun;Yuan Ping Pang;Oksana Lockridge;Stephen Brimijoin.
Molecular Pharmacology (2002)
Neurite Differentiation Is Modulated in Neuroblastoma Cells Engineered for Altered Acetylcholinesterase Expression
C. Koenigsberger;S. Chiappa;S. Brimijoin.
Journal of Neurochemistry (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Ottawa Hospital
University of Nebraska Medical Center
University of Minnesota
Mayo Clinic
Baylor College of Medicine
University of Kentucky
Mayo Clinic
Mayo Clinic
Karolinska Institute
Google (United States)
University of Bologna
University of California, Los Angeles
Sharif University of Technology
Vanderbilt University
Heriot-Watt University
Aarhus University
University of Florida
University of Nevada, Las Vegas
54gene
University of Alaska Fairbanks
Maastricht University
École Normale Supérieure
University of Montpellier
University of Helsinki
Boston Children's Hospital